British pharma giant GSK is heading back to school, pledging up to 50 million pounds sterling (about $62.4 million) to work ...

GSK will invest up to £50 million in the new project, which could inform future development of cancer vaccines.

Alphabet also remains a popular pick among hedge fund managers. According to Insider Monkey data, 202 hedge fund investors ...

GSK plc (LSE/NYSE: GSK) today announced that the European Medicines Agency (EMA) has accepted for review the regulatory application of a prefilled syringe presentation of Shingrix (GSK’s Recombinant ...

Median duration of therapy was 20.5 months for the combination and 16.4 months with single-agent nivolumab. Median number of ...

Kirkland, Latham, Paul Weiss and others have replaced the likes of Sullivan & Cromwell, Clifford Chance and Slaughter and May ...

The company said under a collaboration with the university it would invest £50m over three years to find out whether cancers could be prevented from developing with jabs.

European stocks closed lower on Monday, with several markets falling after several days of gains, due to a sell-off in the tech ...

Pharmacies play a key role in improving drug development and patient care, offering insights, clinical trial support and ...

FTSE rebounds to edge higher amid strong consumer stocks - The FTSE 100 finished 1.36 points higher to end the day at ...

Pharma stocks have underperformed the market in the fourth quarter with the Stoxx Europe 600 Health Care index--which is heavily dominated by Europe's six largest pharma companies--down 9.4% against a ...

Aimed at enhancing U.S. outreach, investor relations, corporate dialogue, and business development (BD) capabilitiesMADRID and CAMBRIDGE, Mass., ...